These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32332109)

  • 1. TGF-β and IL-15 Synergize through MAPK Pathways to Drive the Conversion of Human NK Cells to an Innate Lymphoid Cell 1-like Phenotype.
    Hawke LG; Mitchell BZ; Ormiston ML
    J Immunol; 2020 Jun; 204(12):3171-3181. PubMed ID: 32332109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Production of Pro-angiogenic VEGF-A Isoforms by Hypoxic Human NK Cells Is Independent of Their TGF-β-Mediated Conversion to an ILC1-Like Phenotype.
    Hawke LG; Whitford MKM; Ormiston ML
    Front Immunol; 2020; 11():1903. PubMed ID: 32983113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
    Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T
    Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands.
    Cortez VS; Cervantes-Barragan L; Robinette ML; Bando JK; Wang Y; Geiger TL; Gilfillan S; Fuchs A; Vivier E; Sun JC; Cella M; Colonna M
    Immunity; 2016 May; 44(5):1127-39. PubMed ID: 27156386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling.
    Cortez VS; Ulland TK; Cervantes-Barragan L; Bando JK; Robinette ML; Wang Q; White AJ; Gilfillan S; Cella M; Colonna M
    Nat Immunol; 2017 Sep; 18(9):995-1003. PubMed ID: 28759002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway.
    Song H; Hur DY; Kim KE; Park H; Kim T; Kim CW; Bang S; Cho DH
    Cell Immunol; 2006 Jul; 242(1):39-45. PubMed ID: 17070508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.
    Salomé B; Gomez-Cadena A; Loyon R; Suffiotti M; Salvestrini V; Wyss T; Vanoni G; Ruan DF; Rossi M; Tozzo A; Tentorio P; Bruni E; Riether C; Jacobsen EM; Jandus P; Conrad C; Hoenig M; Schulz A; Michaud K; Della Porta MG; Salvatore S; Ho PC; Gfeller D; Ochsenbein A; Mavilio D; Curti A; Marcenaro E; Steinle A; Horowitz A; Romero P; Trabanelli S; Jandus C
    Blood Adv; 2019 Nov; 3(22):3674-3687. PubMed ID: 31765481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway.
    Yu TK; Caudell EG; Smid C; Grimm EA
    J Immunol; 2000 Jun; 164(12):6244-51. PubMed ID: 10843677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta.
    Eriksson M; Meadows SK; Wira CR; Sentman CL
    J Leukoc Biol; 2004 Sep; 76(3):667-75. PubMed ID: 15178706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.
    Gao Y; Souza-Fonseca-Guimaraes F; Bald T; Ng SS; Young A; Ngiow SF; Rautela J; Straube J; Waddell N; Blake SJ; Yan J; Bartholin L; Lee JS; Vivier E; Takeda K; Messaoudene M; Zitvogel L; Teng MWL; Belz GT; Engwerda CR; Huntington ND; Nakamura K; Hölzel M; Smyth MJ
    Nat Immunol; 2017 Sep; 18(9):1004-1015. PubMed ID: 28759001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an Inhibitory NK Cell Subset by TGF-β1/IL-15 Polarization.
    Chung DC; Garcia-Batres CR; Millar DG; Wong SWY; Elford AR; Mathews JA; Wang BX; Nguyen LT; Shaw PA; Clarke BA; Bernardini MQ; Sacher AG; Crome SQ; Ohashi PS
    J Immunol; 2024 Jun; 212(12):1904-1912. PubMed ID: 38668728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties.
    Van Acker A; Gronke K; Biswas A; Martens L; Saeys Y; Filtjens J; Taveirne S; Van Ammel E; Kerre T; Matthys P; Taghon T; Vandekerckhove B; Plum J; Dunay IR; Diefenbach A; Leclercq G
    Cell Rep; 2017 May; 19(7):1431-1443. PubMed ID: 28514662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells.
    Grund EM; Spyropoulos DD; Watson DK; Muise-Helmericks RC
    J Biol Chem; 2005 Feb; 280(6):4772-8. PubMed ID: 15563472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 regulates the expansion, phenotype, and function of murine NK cells activated by IL-15 and IL-18.
    Oka N; Markova T; Tsuzuki K; Li W; El-Darawish Y; Pencheva-Demireva M; Yamanishi K; Yamanishi H; Sakagami M; Tanaka Y; Okamura H
    Cancer Immunol Immunother; 2020 Sep; 69(9):1699-1712. PubMed ID: 32333080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells.
    Berrien-Elliott MM; Sun Y; Neal C; Ireland A; Trissal MC; Sullivan RP; Wagner JA; Leong JW; Wong P; Mah-Som AY; Wong TN; Schappe T; Keppel CR; Cortez VS; Stamatiades EG; Li MO; Colonna M; Link DC; French AR; Cooper MA; Wang WL; Boldin MP; Reddy P; Fehniger TA
    Immunity; 2019 Sep; 51(3):479-490.e6. PubMed ID: 31402259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression.
    Fujii R; Jochems C; Tritsch SR; Wong HC; Schlom J; Hodge JW
    Cancer Immunol Immunother; 2018 Apr; 67(4):675-689. PubMed ID: 29392336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIS and TGF-β regulatory pathways influence immunity to bacterial infection.
    McCulloch TR; Rossi GR; Schreuder J; Belz GT; Wells TJ; Souza-Fonseca-Guimaraes F
    Immunology; 2022 Sep; 167(1):54-63. PubMed ID: 35611558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
    Ghio M; Contini P; Negrini S; Boero S; Musso A; Poggi A
    Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia.
    Rouce RH; Shaim H; Sekine T; Weber G; Ballard B; Ku S; Barese C; Murali V; Wu MF; Liu H; Shpall EJ; Bollard CM; Rabin KR; Rezvani K
    Leukemia; 2016 Apr; 30(4):800-11. PubMed ID: 26621337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK.
    Jono H; Xu H; Kai H; Lim DJ; Kim YS; Feng XH; Li JD
    J Biol Chem; 2003 Jul; 278(30):27811-9. PubMed ID: 12734193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.